Moneycontrol PRO
you are here: HomeNewsIndia

Coronavirus Update | Active COVID-19 cases cross one lakh mark

Coronavirus Update | The active cases crossed the one lakh mark again after 122 days.

June 30, 2022 / 09:44 AM IST
Representative image (REUTERS/Danish Siddiqui)

Representative image (REUTERS/Danish Siddiqui)

India logged 18,000 new coronavirus infections in a single day after a gap of 130 days, taking the COVID-19 tally to 4,34,52,164, according to the Union Health Ministry data updated on Thursday. The active cases crossed the one lakh mark again after 122 days.

A total 18,819 new Covid cases were reported in a span of 24 hours while the death toll climbed to 5,25,116 with 39 new fatalities, the data updated at 8 am stated. The active cases increased to 1,04,555 comprising 0.24 per cent of the total infections, while the national COVID-19 recovery rate was recorded at 98.55 per cent, the ministry said.

An increase of 4,953 cases has been recorded in the active COVID-19 caseload in a span of 24 hours. The daily positivity rate was recorded at 4.16 per cent and the weekly positivity rate at 3.72 per cent, according to the ministry.

The number of people who have recuperated from the disease surged to 4,28,22,493, while the case fatality rate was 1.21 per cent. According to the ministry, 197.61 crore doses of Covid vaccine have been administered in the country so far under the nationwide COVID-19 vaccination drive.

India's COVID-19 tally had crossed the 20-lakh mark on August 7, 2020, 30 lakh on August 23, 40 lakh on September 5 and 50 lakh on September 16. It went past 60 lakh on September 28, 70 lakh on October 11, crossed 80 lakh on October 29, 90 lakh on November 20 and surpassed the one-crore mark on December 19.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

The country crossed the grim milestone of two crore on May 4, three crore on June 23 last year and four crore on January 25 this year.

(With PTI inputs)
Moneycontrol News
first published: Jun 30, 2022 09:47 am
Sections
ISO 27001 - BSI Assurance Mark